[The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115). 1. Blood levels in dogs].
作者信息
Femmer K, Klemm W, Nürnberger H
出版信息
Pharmazie. 1975 Oct;30(10):673-5.
PMID:694
Abstract
摘要
相似文献
1
2
[The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].[1-(4-环己基脲基苯氧基)-2-羟基-3-叔丁氨基丙烷（他林洛尔，Cordanum，02-115）的药代动力学 2. 大鼠体内14C标记化合物的排泄、血药浓度及分布]
Pharmazie. 1975 Oct;30(10):675-7.
3
4
5
6
7
Kinetics of pamatolol, a cardioselective beta adrenoreceptor blocker.帕马洛尔（一种心脏选择性β肾上腺素能受体阻滞剂）的动力学
Clin Pharmacol Ther. 1979 Dec;26(6):682-5. doi: 10.1002/cpt1979266682.
8
Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.连续服用水飞蓟素对健康志愿者口服他林洛尔药代动力学的影响。
Xenobiotica. 2009 Sep;39(9):694-9. doi: 10.1080/00498250903060077.
9
10
Pharmacokinetics and metabolism of a new beta-adrenergic blocking agent, the 1, ter-butyl-amino-3-(1,2,3,4-tetrahydro-1,4-ethano-8-hydroxy-5-naphthoxy)-2-propanol (K 5407).一种新型β-肾上腺素能阻滞剂1-叔丁基氨基-3-（1,2,3,4-四氢-1,4-亚乙基-8-羟基-5-萘氧基）-2-丙醇（K 5407）的药代动力学和代谢
Eur J Drug Metab Pharmacokinet. 1980;5(1):9-20. doi: 10.1007/BF03189437.
Zotero 插件